MediPharm Labs Corp. (TSX:LABS)
0.0775
-0.0125 (-13.89%)
Jul 17, 2026, 3:20 PM EST
MediPharm Labs Market Cap
MediPharm Labs has a market cap or net worth of CAD 33.11 million as of July 17, 2026. Its market cap has increased by 12.40% in one year.
Market Cap
33.11M
Enterprise Value
22.78M
Revenue
43.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since October 5, 2018, MediPharm Labs's market cap has decreased from 213.11M to 33.11M, a decrease of -84.46%. That is a compound annual growth rate of -21.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 33.11M | 21.05% |
| Dec 31, 2025 | 27.35M | 10.87% |
| Dec 31, 2024 | 24.67M | -5.43% |
| Dec 29, 2023 | 26.08M | 32.06% |
| Dec 30, 2022 | 19.75M | -60.54% |
| Dec 31, 2021 | 50.06M | -39.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vext Science | 61.92M |
| Grey Wolf Health | 55.19M |
| Charlotte's Web Holdings | 54.61M |
| BioNxt Solutions | 50.34M |
| LSL Pharma Group | 43.09M |
| ZYUS Life Sciences | 39.86M |
| C21 Investments | 37.98M |
| Mountain Valley MD Holdings | 36.56M |